Navigation Links
How what and how much we eat (and drink) affects our risk of cancer
Date:4/13/2008

alance inhibits, while positive energy balance enhances, signaling through these pathways, thereby modulating cellular growth, proliferation, and survival, said Tricia Moore, lead author of the study.

Dietary energy balance refers to the balance between caloric intake and energy expenditure, according to the report. Previous findings from both epidemiological and experimental studies suggest chronic positive energy balance, which can lead to obesity, increases the risk of developing multiple cancers. However, a negative energy balance state, as induced by calorie restriction, decreases these risks in most instances, the researchers said.

In the present study, the researchers used a two-stage skin carcinogenesis model to examine the effects of both positive and negative dietary energy balance on skin tumor promotion and progression. Groups of female mice received 25 nmol of 7,12-dimethylbenz(a)anthracene (DMBA), a cancer inducing chemical, and were then placed on one of four dietary treatment regimens to generate either a positive or negative energy balance state. After four weeks on their respective diets, the mice received two other cancer inducing chemicals (acetone, 3.4 nmol or 6.8 nmol 12-O-tetradecanoylphorbol-13-acetate (TPA)) twice weekly for the duration of the study.

Negative energy balance, as induced by both 15 percent and 30 percent calorie restriction, led to inhibition of papilloma (benign skin tumors that can potentially lead to skin cancer) formation, depending on TPA dose, when compared to either positive energy balance inducing diet. Although tumor multiplicity, as measured by papillomas per mouse, was slightly higher among those receiving the more calorie dense fat diet, this was not different from the less calorie dense fat diet with either dose of TPA, the researchers noted. The impact of dietary energy balance manipulation on the conversion of papillomas to squamous cell carcinomas in this model of multistage
'/>"/>

Contact: Staci Vernick Goldberg
Staci.goldberg@aacr.org
267-646-0616
American Association for Cancer Research
Source:Eurekalert

Page: 1 2 3 4 5 6 7

Related biology news :

1. T-cadherin affects blood vessel growth in breast cancer, hormone from fat cells may play a role
2. Study finds pitching mound height affects throwing motion, injury risk
3. Gene dose affects tumor growth
4. Restless legs syndrome affects nearly 2 percent of US/UK children
5. Gender, coupled with diabetes, affects vascular disease development
6. Stem cells and cancer: cancer pathways that also control the adult stem cell population
7. Evidence now suggests eating soy foods in puberty protects against breast cancer
8. Distance learning course in radiation oncology for cancer treatment
9. AACR annual meeting showcases developments in understanding and targeting cancers
10. MU researcher links hormone replacement therapy to breast cancer
11. Genetic Engineering & Biotechnology News reports on cancer biomarkers

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...YETTE, Ind. - Purdue University scientists have he...sponsible for cell wall development in maize, an e...to produce the biomass best suited for biofuels pr...as Carpita, a professor of plant cell biology, pub...n the journal Plant Physiology on Thursday (Nov....
(Date:11/19/2009)...iller, University of Cincinnati professor of paleo..., and co-author Michael Foote of the University of...ue of Science with their paper, "Epicontinental ...ass Extinction and Origination." , For many year...istory of biodiversity have focused on charting th...
(Date:11/19/2009)...e Jaffrey Receives Competitive NIH Director,s T-R0...Glow in the Dark , Dr. Samie Jaffrey, associate ... College, is among the first researchers to win a ...d from the National Institutes of Health. Dr. Jaff...rotein recognition technologies that may some day ...
Breaking Biology News(10 mins):Maize cell wall genes identified, giving boost to biofuel research 2Paleontologists find extinction rates higher in open-ocean settings during mass extinctions 2Paleontologists find extinction rates higher in open-ocean settings during mass extinctions 3Paleontologists find extinction rates higher in open-ocean settings during mass extinctions 4Weill Cornell science briefs: November 2009 2Weill Cornell science briefs: November 2009 3Weill Cornell science briefs: November 2009 4Weill Cornell science briefs: November 2009 5Sundia Receives the Highest Growth Potential Award from Zhangjiang 55681 1Sundia Receives the Highest Growth Potential Award from Zhangjiang 55681 2IDRI to Use NanoPass Microneedle Technology for Intradermal Vaccines and Diagnostic Skin Tests 55679 1IDRI to Use NanoPass Microneedle Technology for Intradermal Vaccines and Diagnostic Skin Tests 55679 2BloodStor 28TM 29 Stem Cell Biopreservation Media Platform Launched by BioLife Solutions 13734 1BloodStor 28TM 29 Stem Cell Biopreservation Media Platform Launched by BioLife Solutions 13734 2BloodStor 28TM 29 Stem Cell Biopreservation Media Platform Launched by BioLife Solutions 13734 3
... New cancer research from the University of Misso...product could be the key to unlocking the prostate...tive effect of tomato products has been suggested ...ot know exactly what caused this effect. , It app...toes comes from rehydrating tomato powder into tom...
...rom the European Molecular Biology Laboratory (EMB...ioinformatics Institute (EMBL-EBI) in Hinxton, UK,...es are regulated. A chromatin modifying enzyme hel...e copy of the sex chromosome X, while females have...male sex chromosomes in fruit flies and binds to d...
...emic health centers in 11 states are the latest me...al and Translational Science Award (CTSA) consorti...institutions across the nation, the consortium is ... discoveries to become treatments for patients and...s. It also is fulfilling the critical need to trai...
Other Biology News:X chromosome exposed 2NIH expands national consortium dedicated to transforming clinical and translational research 2NIH expands national consortium dedicated to transforming clinical and translational research 3
(Date:11/19/2009)...ewswire/ -- Dr. Mate Hidvegi, inventor of Avemar f...elease issued on November 17 by Biropharma Kft, di...and self-serving statements about its U.S. competi...d from his office in Budapest, Hungary: ,, "Th...t apply to AveULTRA, www.aveultra.com , is misl...
(Date:11/19/2009)...wswire-FirstCall/ -- Spherix Incorporated (Nasdaq:...es therapy, and a provider of technical and regula...echnology and pharmaceutical companies, today anno...hareholders. ,, At the meeting, shareholders of... following members to the Board of Directors: ,...
(Date:11/19/2009)...e/ - Aegera Therapeutics Inc. announced today the ...2B study of AEG35156, a targeted antisense therape...y indications. ,, The study, entitled "An Open-...ibitor of Apoptosis (XIAP) Antisense AEG35156 Give...rubicin in AML Following Failure of a Single Stand...
(Date:11/19/2009)...nored by latest award for revolutionary hearing ai...ovember 16, 2009 -- Popular Science Magazine has n... from InSound Medical a winner of its coveted Best...    Chosen from thousands of e...earing canal for up to four months while providing...
Breaking Biology Technology:American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 3
...nochannel Chip and Reader for,Single-Molecule Mapp... Long Strands of DNA in Context and at Very...matrix, Inc., a developer,of breakthrough nanoscal...ostics, personalized medicine and biomedical resea...ational Human Genome Research Institute of the,U.S...
...Capital,("Denham") announced today that it will in...G"). VitAG technology converts municipal biosolids...ct capable of competing with and,outperforming con...e,construction of multiple biosolids-to-fertilizer...itAG is an opportunity for Denham to,participate i...
....53; Adjusted EPS $0.48, CORONA, Calif., Aug. 6 ...ing specialty pharmaceutical,company, today report...June,30, 2008., Second Quarter 2008 Results, Net...llion and net,income was $60.3 million, or $0.53 p...r 2008 included a gain related to a milestone paym...
Other Biology Technology:BioNanomatrix Awarded New NIH Grant for Development of Nanoscale Platform for Single-Molecule DNA Mapping and Haplotype Applications 2BioNanomatrix Awarded New NIH Grant for Development of Nanoscale Platform for Single-Molecule DNA Mapping and Haplotype Applications 3Denham Capital to Invest $60 Million in VitAG, Recycler of Municipal Biosolids 2Watson Pharmaceuticals Reports Second Quarter 2008 Results 2Watson Pharmaceuticals Reports Second Quarter 2008 Results 3Watson Pharmaceuticals Reports Second Quarter 2008 Results 4Watson Pharmaceuticals Reports Second Quarter 2008 Results 5Watson Pharmaceuticals Reports Second Quarter 2008 Results 6Watson Pharmaceuticals Reports Second Quarter 2008 Results 7Watson Pharmaceuticals Reports Second Quarter 2008 Results 8Watson Pharmaceuticals Reports Second Quarter 2008 Results 9Watson Pharmaceuticals Reports Second Quarter 2008 Results 10Watson Pharmaceuticals Reports Second Quarter 2008 Results 11Watson Pharmaceuticals Reports Second Quarter 2008 Results 12Watson Pharmaceuticals Reports Second Quarter 2008 Results 13Watson Pharmaceuticals Reports Second Quarter 2008 Results 14Watson Pharmaceuticals Reports Second Quarter 2008 Results 15Watson Pharmaceuticals Reports Second Quarter 2008 Results 16Watson Pharmaceuticals Reports Second Quarter 2008 Results 17
Viral CCI, Unconjugated, Fc Chimera from R&D Systems
DeStreak Reagent from GE Healthcare, formerly Amersham Biosciences
Cytotoxicity Fluorometric (green / red) Assay Kit, LIVE/DEAD® from Molecular Probes (Invitrogen)
SlowFade Antifade Kit with DAPI from Molecular Probes (Invitrogen)
Biology Products: